ZAR1L anticorps (AA 51-150) (Cy7)
Aperçu rapide pour ZAR1L anticorps (AA 51-150) (Cy7) (ABIN1707481)
Antigène
Voir toutes ZAR1L AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 51-150
-
Réactivité croisée
- Humain
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human ZAR1L
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Date de péremption
- 12 months
-
-
- ZAR1L (Zygote Arrest 1-Like (ZAR1L))
-
Autre désignation
- ZAR1L
-
Sujet
-
Synonyms: RP11-37E23.4, ZAR1-like protein, ZAR1L, ZAR1L_HUMAN, ZAR2, Zygote arrest 1 like.
Background: This gene encodes a member of the ZAR1 family that is predominantly expressed in oocytes and early embryos. The protein may function as an RNA regulator in early embryos.
Antigène
-